Juno Therapeutics' (JUNO) Market Perform Rating Reiterated at Wells Fargo & Co

With 44,000 avg volume, 125 days are for AIA GROUP LTD (OTCMKTS:AAIGF)'s short sellers to cover AAIGF's short positions. It closed at $19.16 lastly. Blackrock Florida Municipal 202 (BFO) has declined 0.62% since January 17, 2017 and is downtrending. It has underperformed by 6.43% the S&P500. Advisor Group Inc. grew its position in Juno Therapeutics by 141.1% in the third quarter. (NASDAQ:JUNO) for 200 shares. The shares were sold at an average price of $48.21, for a total value of $613,424.04. Juno Therapeutics, Inc. (NASDAQ:JUNO)'s RSI (Relative Strength Index) is 38.68. It has underperformed by 56.55% the S&P500.The move comes after 8 months positive chart setup for the $7.64 billion company. They now have a $63.00 target price on the biopharmaceutical company's stock, up from their prior target price of $54.00. Corporate insiders own 15.08% of the company's stock. The company has market cap of $9.86 million. The firm offers life, medical, accident, critical illness, and disability protection insurance, as well as savings plans for individuals. It has a 8.37 P/E ratio.

Juno Therapeutics, Inc (Juno) is a biopharmaceutical company, which is focused on developing cellular immunotherapies for the treatment of cancer. The insider, KLAUSNER RICHARD, now holds 728,775 shares of JUNO. They expect $-1.02 earnings per share, down 54.55% or $0.36 from last year's $-0.66 per share. Moreover, Brown Advisory has 0.04% invested in Juno Therapeutics, Inc. The company has market cap of $7.58 billion.

Chimeric antigen receptor T-cell therapy, or vehicle T, harnesses the body's own immune cells to recognize and attack malignant cells. This doesn't look much better, as earnings seem to have steadily been getting more and more negative over time. The Company's CD19 product candidates include JCAR017 that is in Phase I/II trials for adults with relapsed or refractory B cell aggressive non-Hodgkin lymphoma (NHL) and pediatric patients with r/r B cell acute lymphoblastic leukemia (ALL); JCAR014, which is in Phase I/II trials to treat various B cell malignancies in patients relapsed or refractory to standard therapies; and JCAR015 that is in Phase II trials for adult patients with r/r ALL.

Another important element to consider is the price target and recommendations from brokerage firm analysts. Therefore 56% are positive.

Late and Lesser       Analysts expect Gilead's cell therapy entry to outsell Juno's              Source Bloomberg
Late and Lesser Analysts expect Gilead's cell therapy entry to outsell Juno's Source Bloomberg

According to Juno Therapeutics, Inc.'s latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 69.95%. The stock has "Mkt Perform" rating by Raymond James on Tuesday, December 6. Morgan Stanley maintained it with "Equal-Weight" rating and $27 target in Monday, August 7 report. Leerink Swann maintained the stock with "Outperform" rating in Thursday, November 2 report. FBR & Co reissued an "outperform" rating and issued a $61.00 price target on shares of Juno Therapeutics in a research report on Saturday, October 15th. Goldman Sachs initiated Juno Therapeutics, Inc.

Analysts await Juno Therapeutics, Inc. The Manufacturers Life Insurance Company boosted its stake in shares of Juno Therapeutics by 7.2% during the second quarter. The company was downgraded on Thursday, October 29 by Standpoint Research. (NASDAQ:JUNO) on Wednesday, November 18 with "Neutral" rating. The firm has "Outperform" rating by Raymond James given on Thursday, June 2.

Investors sentiment increased to 1.44 in 2017 Q3. Its down 0.21, from 1.17 in 2017Q2. It improved, as 26 investors sold Juno Therapeutics, Inc. shares while 46 reduced holdings. Credit Suisse AG raised its position in shares of Juno Therapeutics by 51.1% in the third quarter. (NASDAQ:JUNO). Sei Invests holds 0% or 1,291 shares in its portfolio.

Ownership at Juno Therapeutics, Inc. (NASDAQ:JUNO). First Fin Corporation In invested 0.01% in Juno Therapeutics, Inc. (NASDAQ:JUNO) or 538,800 shares. Bamco Inc. NY now owns 443,107 shares of the biopharmaceutical company's stock worth $13,298,000 after buying an additional 342,582 shares during the period. Its down 6.23% from 621,200 shares previously. Barclays Public Limited Company holds 0.01% or 237,087 shares in its portfolio. Gsa Cap Prtnrs Llp invested in 37,120 shares or 0.05% of the stock. Partner Inv LP has 0.84% invested in Juno Therapeutics, Inc. (NASDAQ:JUNO). Panagora Asset Mngmt Inc accumulated 4,200 shares. Profund Advsrs Ltd Limited Liability Company, a Maryland-based fund reported 33,445 shares.

(Copyright © 2015. All Rights Reserved.)
 
Recommended

Bitcoin prices fall as S Korea says ban still an option
Mati Greenspan, senior market analyst for eToro, said low trading in Korea and Japan may have contributed to the price movement. They were described as Ponzi schemes and eventually the Chinese government also banned ICOs .

Rats may be wrongly blamed for the Black Death
Plague is a common disease that is caused by bacteria called Yersinia pestis , which are carried by rodents and their fleas. Symptoms include painful, swollen lymph nodes, called bubos, as well as fever, chills and coughing.

Emre Can Delivered Dominant Manchester City Performance While Ill
Emre Can's contract expires at the end of the season and it's looking increasingly likely that the German will join Juventus on a free transfer.

Durbin spokesman: GOP senators have 'credibility problem'
In another tweet , Marter wrote , 'Yesterday, Senators Cotton and Perdue "could not recall" what the president said. In a separate televised appearance, Arkansas Senator Tom Cotton also defended the president.

Bannon Subpoenaed in Russian Probe
He predicts Trump will remain healthy for the duration of his presidency despite limited exercise and a diet heavy on fast food. House of Representatives committee that is probing whether Russian Federation meddled in the 2016 presidential election.

48 injured as school bus rams into building in Eberbach, Germany
A SCHOOL bus crash in Germany early this morning injured 47 kids - at least 10 of them seriously. A collecting point for parents and uninjured children was set up in the Güterbahnhofstrasse.

Mkhitaryan suits Arsenal, but Mourinho getting better deal, says ex
When asked if Chelsea are actively trying to sign Sanchez, Conte said: "I don't know". But, I think most probably, a player like him has other big clubs interested.

50 per cent rural youth never used Net
While 46 per cent of the former can perform arithmetic division, only 29 per cent of the latter can do the same. Most indicators for northeastern states fall behind these indicators that represent basic scholastic ability.

WR Kevin Stepherson among four players dismissed by Notre Dame
As a junior, Tiassum recorded two tackles this season and wasn't expected to see much time on the field as a senior. Stepherson had also been pulled over and cited for pot possession the day before his shoplifting arrest.

JJ Abrams to Return to TV with Space Drama
He created or co-created shows as diverse and exciting as Felicity , Alias , Fringe , and most importantly for this writer: Lost . Abrams is also working alongside writer/director Quentin Tarantino on a new film in the " Star Trek " franchise as well.

Momentum unstoppable as Jeremy Corbyn allies win control
Is that what we have said to the European Union in opposition? Yes. "What we have called for is a meaningful vote in Parliament". Asked why the party has not yet had a woman as leader she said: "Watch this space".

Girl dies after being pinned between vehicles during school pickup
Officers say the unoccupied Kia SUV, which may have switched gears, pinned the girl against her father's Mercedes-Benz. A five-year-old girl was killed yesterday after she was hit by an unoccupied SUV near her school (St.

Bannon ordered to testify to grand jury
He says White House chefs are working to reduce Trump's intake of calories, fats and carbs. As prosecutors hunt for criminal misdeeds, they have a number of arrows in their quiver.

African nations slam Trump's vulgar remarks as 'reprehensible and racist'
Mr Graham also attended the meeting. "I expect that our assistance programmes would continue pretty much as they are", he said. Paul added that he wanted to see immigration reform but felt it was hard if folks continue to criticize Trump.

Trump declares 'I'm not a racist'
The U.S. president spoke out amid the global furor over vulgar remarks he's said to have made about Africa and Haiti. "No. Tom Cotton and David Purdue, who were both at the White House meeting, said the President did not say "sh-hole".


More News

News
More News